What is synthetic biology and what's its potential? These stories explain
Synthetic biology is the engineering and redesign of biological systems and could have a range of applications in modern day life.
Natsai Audrey Chieza, founder and CEO of Faber Futures, is a visionary designer and thought leader with a background in Architectural Design and Material Futures. She fervently champions biodesign initiatives that integrate living systems into solutions to global challenges.
Founded in 2018 and based in London, Faber Futures bridges the gap between scientific advancements and real-world applications, fostering a resilient bioeconomy through collaborations with biotechnology and creative industries. Clients include Ginkgo Bioworks, World Economic Forum, and Arcaea. At the same time, renowned cultural institutions like the Cooper Hewitt, Design Museum and La Biennale di Venezia have awarded commissions to the agency. Through its R&D capabilities, Faber Futures develops proprietary biotechnologies for textile dye finishing, finding applications in apparel and fashion, while reflecting the company's commitment to advancing the field through deep engagement across multiple domains.
As a member of the World Economic Forum's Global Futures Council on Synthetic Biology, Natsai offers insights into policy development for a mission-oriented bioeconomy. A TED speaker and educator, she advocates for cross-disciplinary collaboration to address planetary challenges through essential systems change. Recognised with the prestigious INDEX award in 2019 and acknowledged on lists like ICON Design 100 and Evening Standard Progress 1000, Chieza's work leads a growing movement towards biophilic futures through biodesign.